Home page
MyAlcon for Consumers

MyAlcon | Finland

This page is available in English. Please click below for other locations.

Select another location

Complete Confidence:
The Alcon Advantage

IOL Options for Every Patient

 

Complete Confidence: The Alcon Advantage

 

IOL Options for Every Patient

 

 

AcrySof IQ Vivity™ IOL

 

The first and only presbyopia-correcting IOL with wavefront-shaping technology.1-4

See More
A close-up shot of a car’s left passenger side headlight illuminating the dark. A vertical line divides the headlight in two, with a starburst effect on the light on the left side of the line.

Clareon™ PanOptix™ IOL

 

PanOptix™ delivers an exceptional high-quality visual experience from far to near, with 99% patient satisfaction and over 2.2 million implants worldwide.5-9

See More
A picture of a hand holding a gold medal. Gold laurels and a caduceus appear on the medal.

AcrySof™ IQ Monofocal IOL and AcrySof™ IQ Toric IOL

 

The trusted IOLs that give you confidence.10

See More
An image of printed research papers placed on the ground in such a way that the borders of the papers create the outline of an IOL. An iPad lies on top of the papers, displaying a title page to a study on the AcrySof IQ platform. A blue medical mask lies next to the iPad. This all appears on a grey background.

Clareon™ Monofocal IOL and Clareon™ Toric IOL

 

Our most advanced lens design that delivers pristine visual outcomes.10-12

See More
A close-up image of two intraocular lenses overlaid with a blue background.

Alcon Experience Academy

 

For relevant training content from industry thought leaders

Visit AEA Portal

References:
1. AcrySof IQ Vivity™ Extended Vision IOL Directions for Use.
2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.
3. Alcon Data on File. TDOC-0055575. 09 Apr 2019.
4. Alcon Data on File. TDOC-0055576. 09 Apr 2019.
5. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
6. Zhu et al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C.
7. Market Scope 2022 IOL Market Report.
8. Alcon Data on File, 2022. [REF-18881].
9. Clareon™ PanOptix™ Trifocal IOL Directions for Use.
10. Clareon™ IOL Directions for use.
11. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.
12. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.

 

Medical Devices manufactured by Alcon comply with all applicable laws and regulations. For indications, contraindications, warnings and serious incidents please refer to the relevant product’s direction for use or operator manuals.

©2023 Alcon Inc. 04/23 NORD-ACI-2300002
Finland
Alcon See Briliantly